Cellectar Biosciences Inc (CLRB) Live Share Price, Invest From India

Cellectar Biosciences Inc Stock Performance

as on March 4, 2026 at 6:04 am IST

Day's Low
Day's High
$2.66
Day's Price Range
$3.06
$2.76
3.62%
Downside
10.87%
Upside
52 Week's Low
52 Week's High
$2.45
52-Week Price Range
$20.59
$2.76
11.23%
Downside
646.18%
Upside

Cellectar Biosciences Inc share price movements today

Previous Close: $2.99
Open: $2.98
Volume: 577.5K
Day's Low - High: $2.66 - $3.06
52 Week Low - High: $2.45 - $20.59

Cellectar Biosciences Inc Historical Returns

1 Month Return: -4.17 %
3 Month Return: -18.97 %
1 Year Return: -63.92 %
3 Year Return: -94.7 %
5 Year Return: -99.46 %

Cellectar Biosciences Inc Stock Fundamentals & Key Indicators

Check Cellectar Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.8M

EPS (TTM)

-9.27

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-29.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-145.42%

Cellectar Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cellectar Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cellectar Biosciences Inc	BUY	$13.8M	-99.46%	NA	0.00%
Vertex Pharmaceuticals Incorporated	BUY	$126.2B	133.18%	32.47	32.94%
Alnylam Pharmaceuticals, Inc.	BUY	$44.2B	125.24%	142.88	8.45%
Beone Medicines Ltd	NA	$35.1B	NA	621.55	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$82.6B	77.02%	18.83	31.41%

Stock Returns calculator for Cellectar Biosciences Inc Stock including INR - Dollar returns

The Cellectar Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cellectar Biosciences Inc investment value today

Current value as on today

₹38,798

Returns

₹61,202

(-61.2%)

Returns from Cellectar Biosciences Inc Stock

₹66,707 (-66.71%)

Dollar Returns*

₹5,505 (+5.5%)

Analyst Recommendation on Cellectar Biosciences Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Cellectar Biosciences Inc. Average target price of $47

Cellectar Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Cellectar Biosciences Inc.

What analysts predicted

94.13%UPSIDE

Target Price

$47

Current Price

$2.76

Analyzed by

10 Analysts

Target

$47.00

Cellectar Biosciences Inc target price $47, a slight upside of 94.13% compared to current price of $2.76. According to 10 analysts rating.

Cellectar Biosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Cellectar Biosciences Inc Stock has decreased by -89% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 2, 2026 to March 4, 2026

Change:-89% versus previous 30 day period

Cellectar Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	0	0	-	-	0	-	-	-
Gross Profit	0	0	0	0	-	0	0	0	-	0
Operating Income	-8	-9	-12	-12	-13	-13	-12	-6	-6	-4
EBITDA	-8	-9	-12	-11	-	-13	-12	-6	-5	-4
Interest Expense	-	-	0	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-17	-7	-26	0	-14	-2	-6	-5	-4
Income Tax Expense	0	0	0	0	-	0	0	-	-	-
Net Income	-10	-17	-7	-26	0	-14	-2	-6	-5	-4
Net Profit Margin	0.00%	0.00%	-2385.57%	-8064.38%	0.00%	0.00%	-762.20%	0.00%	0.00%	0.00%

Cellectar Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-1	0	0	0	0	0	0	0
Operating Income	-8	-9	-13	-13	-14	-15	-24	-28	-38	-51
EBITDA	-11	-9	-12	-13	-13	-14	-23	-28	-38	-51
Interest Expense	0	0	0	0	0	0	0	0	-	-
Depreciation	-	-	1	0	0	0	0	0	0	0
Income Before Tax	-5	-6	-13	-13	-14	-15	-24	-28	-42	-44
Income Tax Expense	-3	-3	0	-1	0	0	0	0	0	0
Net Income	-5	-6	-13	-13	-14	-15	-23	-28	-42	-44
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cellectar Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-17	-7	-26	0	-14	-2	-6	-5	-4
Operating Cash Flow	-8	-9	-13	-14	-9	-10	-9	-5	-4
Investing Cash Flow	0	0	0	-	0	0	-	0	-
Financing Cash Flow	22	0	43	0	17	-	-	2	5
Change in Cash	13	-9	30	-14	8	-10	-9	-2	1

Cellectar Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-6	-13	-13	-14	-15	-24	-28	-42	-44
Operating Cash Flow	-8	-11	-11	-11	-13	-22	-25	-32	-47
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	15	9	15	9	60	1	9	22	61
Change in Cash	7	-1	3	-2	46	-21	-15	-10	13

Global Institutional Holdings in Cellectar Biosciences Inc

Funds	Holdings
Morgan Stanley - Brokerage Accounts	0.03%
Advisor Group Holdings, Inc.	0%
JONES FINANCIAL COMPANIES LLLP	0%
Citigroup Inc	0%
Vanguard Group Inc	5.8%

See all

Insights on Cellectar Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.5% return, outperforming this stock by 97.4%
NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 155.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CLRB stock has moved down by -11.0%

About Cellectar Biosciences Inc

cellectar biosciences is developing phospholipid drug conjugates (pdcs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. cellectar's pdc platform is based on the company's proprietary phospholipid ether analogs. these novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. cellectar's pdc pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. the company's lead therapeutic pdc, clr 131, utilizes iodine-131, a cytotoxic radioisotope, as its payload. clr 131 has been designated as an orphan drug by the us fda and is currently being evaluated in a phase 1 clinical study in patients with relapsed or refractory multiple myeloma and a phase 2 clinical study to assess efficacy in a range of b-cell malignancies. the company is also developing proprietary pdcs for targeted delivery of chemotherapeutics and has several preclinical stage p

Organisation	Cellectar Biosciences Inc
Headquarters	100 Campus Drive, Florham Park, NJ, United States, 07932
Industry	Health Technology
CEO	Mr. James V. Caruso
E-voting on shares	Click here to vote

Key Management of Cellectar Biosciences Inc

Name	Title
Mr. James V. Caruso	President, CEO & Director
Mr. Chad J. Kolean CPA	VP, CFO & Secretary
Mr. Jarrod Longcor	Chief Operating Officer

FAQs

What is Cellectar Biosciences Inc share price today?

Cellectar Biosciences Inc share price today is $2.76 as on March 4, 2026 at 12:34 am IST. Cellectar Biosciences Inc share today touched a day high of $3.06 and a low of $2.66.

What is the 52 week high and 52 week low for Cellectar Biosciences Inc share?

Cellectar Biosciences Inc share touched a 52 week high of $20.59 on June 4, 2025 and a 52 week low of $2.45 on December 17, 2025. Cellectar Biosciences Inc stock price today i.e. March 4, 2026 at 12:34 am IST is trending at $2.76,which is 86.60% down from its 52 week high and 12.65% up from its 52 week low.

What is Cellectar Biosciences Inc's market capitalisation today?

Cellectar Biosciences Inc market capitalisation is $0.00T as on March 4, 2026 at 12:34 am IST.

How to invest in Cellectar Biosciences Inc Stock (CLRB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cellectar Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cellectar Biosciences Inc Shares that will get you 0.5435 shares as per Cellectar Biosciences Inc share price of $2.76 per share as on March 4, 2026 at 12:34 am IST.

What is the minimum amount required to buy Cellectar Biosciences Inc Stock (CLRB) from India?

Indian investors can start investing in Cellectar Biosciences Inc (CLRB) shares with as little as ₹92.074 or $1 (as of March 4, 2026 at 12:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Cellectar Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on March 4, 2026 at 12:41 am IST). Based on Cellectar Biosciences Inc share’s latest price of $2.76 as on March 4, 2026 at 12:34 am IST, you will get 3.6232 shares of Cellectar Biosciences Inc. Learn more about fractional shares .

What are the returns that Cellectar Biosciences Inc has given to Indian investors in the last 5 years?

Cellectar Biosciences Inc stock has given -99.46% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?